Literature DB >> 646848

Connective tissue components in normal and atherosclerotic human coronary arteries.

M Tammi, P O Seppälä, A Lehtonen, M Möttönen.   

Abstract

Human coronary arteries with various degrees of atherosclerosis were analyzed for the concentration of different types of glycosaminoglycans (GAGs). The changes in GAGs were considered against the background of macroscopic atherosclerosis, and the concentration of glycoprotein-bound hexosamines, collagen, calcium and cholesterol. The concentration of calcium was increased and that of hyaluronic acid decreased even in mildly atherosclerotic coronary arteries. The additional changes in advanced atherosclerosis included the increase of collagen and dermatan sulphate and the decrease of heparan sulphate. Cholesterol was increased in mild, and even further in advanced, atheroslcerosis. The concentrations of chondroitin sulphates and glycoprotein-bound hexosamines were not significantly affected by atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646848     DOI: 10.1016/0021-9150(78)90007-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways.

Authors:  Cheng-Hsun Lu; Chia-Huei Lin; Ko-Jen Li; Chieh-Yu Shen; Cheng-Han Wu; Yu-Min Kuo; Ting-Syuan Lin; Chia-Li Yu; Song-Chou Hsieh
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

2.  Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.

Authors:  I J Edwards; W D Wagner; R T Owens
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Acidic glycosaminoglycans in human coronary arteries, with special reference to the presence of heparin or related glucosaminoglycan.

Authors:  K Murata; Y Yokoyama
Journal:  Experientia       Date:  1981-11-15

4.  Cardiovascular Risk and Serum Hyaluronic Acid: A Preliminary Study in a Healthy Population of Low/Intermediate Risk.

Authors:  Chrysanthi Papanastasopoulou; Maria Papastamataki; Petros Karampatsis; Eleni Anagnostopoulou; Ioannis Papassotiriou; Nikolaos Sitaras
Journal:  J Clin Lab Anal       Date:  2016-06-16       Impact factor: 2.352

5.  Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque.

Authors:  L Heickendorff; T Ledet; L M Rasmussen
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

6.  Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus.

Authors:  F Wasty; M Z Alavi; S Moore
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

7.  Distribution of hyaluronan in articular cartilage as probed by a biotinylated binding region of aggrecan.

Authors:  J J Parkkinen; T P Häkkinen; S Savolainen; C Wang; R Tammi; U M Agren; M J Lammi; J Arokoski; H J Helminen; M I Tammi
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

8.  Immunolocalization of proteoglycan types in aortas of pigeons with spontaneous or diet-induced atherosclerosis.

Authors:  R A Robbins; W D Wagner; L M Sawyer; B Caterson
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

Review 9.  Elastic tissue disruption is a major pathogenic factor to human vascular disease.

Authors:  María M Adeva-Andany; Lucía Adeva-Contreras; Carlos Fernández-Fernández; Manuel González-Lucán; Raquel Funcasta-Calderón
Journal:  Mol Biol Rep       Date:  2021-06-15       Impact factor: 2.316

10.  Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys.

Authors:  Iris J Edwards; Janice D Wagner; Catherine A Vogl-Willis; Kenneth N Litwak; William T Cefalu
Journal:  Cardiovasc Diabetol       Date:  2004-04-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.